To explore the mechanism by which CDK5 silencing inhibited ovarian cancer cell growth and enhanced paclitaxel sensitivity, we first examined the effect of CDK5 knockdown on activation of AKT by detecting Ser473 phosphorylation of AKT. The gene discussed is CDK5; the disease is ovarian carcinoma.